Jim et. al.,
BCHE has finished presenting at RS conference. Considering the general post conference sell off happening in many of the presenting stocks, BCHE seems to be holding up OK.
Wednesday, December 1, 1999
Grand Ballroom Wedgwood Room Regency Room Cotillion Room
7:30 a.m. Registration and Continental Breakfast — Garden Foyer
8:00 a.m. COR Therapeutics a,b Versicor Cimtek Commerce ResMed
8:30 a.m. Boston Scientific OnHealth Network ACTELION Progenics a,b
9:00 a.m. Health Management ChannelPoint AeroGen TRANSGENE a,b
9:30 a.m. Ares-Serono Axys Pharmaceuticals a Phase Forward QIAGEN
10:00 a.m. BioChem Pharma a INSMED Eurand MedQuist a,b
10:30 a.m. Chemdex a,b Neurocrine Biosciences a Rigel ArthroCare a,b
11:00 a.m. Celltech Chiroscience DepoMed The Medicines Co. Trimeris a,b
1:30 p.m. Forest Laboratories Vical Eclipsys a,b LifePoint Hospitals
2:00 p.m. eBenX Aurora Biosciences a,b Pain Therapeutics Biomatrix
2:30 p.m. Miravant Medical a Confer Software GPC Genome Pharma. H. Lundbeck
3:00 p.m. Abgenix a,b Medical Tech. Overview Molecular Circuitry Anesta a,b
Wade King, M.D.
3:30 p.m. Genzyme Ethypharm Pharma Mar Axolotl/AccentHealth
Cheers, Tuck |
